Search For "metformin"
Daewoong Pharmaceutical has obtained approval for SGLT2i + metformin combi
Updated : 2 years, 7 months ago IST
Seoul [South Korea], July 19: Daewoong Pharmaceutical obtained approval for a SGLT-2 inhibitor+metformin combination drug in just one month after the release of Envlo Tab., the 1st SGLT-2 inhibitor by Korea, expanding its product portfolio.
Read More
Treating COVID with Metformin reduces Long COVID rates
Updated : 2 years, 9 months ago IST
Minneapolis [US], June 10: A new study published in The LancetInfectious Diseases supported by the Parsemus Foundation found a 41 per cent reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42 per cent reduction in emergency roo
Read More
Metformin lowers risk of long Covid: Study
Updated : 2 years, 9 months ago IST
University of Minnesota researchers discovered that metformin, a medicine typically used to treat diabetes, reduces the development of protracted COVID in a recent study published in The Lancet Infectious Diseases.
Read More
Glenmark launches drug for treating type 2 diabetes
Updated : 3 years, 2 months ago IST
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Read More
Alkem launches first time in India FDC of Dapagliflozin, Sitagliptin and M
Updated : 3 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 6 (ANI/PRNewswire): Alkem Laboratories Limited, the 5th largest Indian pharmaceutical company, has launched for the first time in India, triple drug fixed dose combination (FDC) of Dapagliflozin, Sitagliptin and Metformin under the brand name of Dapanorm
Read More
Computer drug simulations offer warning about promising diabetes, cancer t
Updated : 4 years ago IST
Waterloo [Canada], February 28 (ANI): Using computer drug simulations, a team of researchers found that doctors need to be wary of prescribing a particular treatment for all types of cancer and patients.
Read More
Glenmark becomes the first company to launch Remogliflozin + Vildagliptin
Updated : 4 years, 4 months ago IST
Mumbai (Maharashtra) [India], October 26 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), a research-led global pharmaceutical company has launched a fixed-dose combination (FDC) of its novel, patent-protected, globally researched Sodium-Glucose Co-Transporter Inhibitor (SGLT2i
Read More
Study: Use of Metformin diminishes danger of death for patients with COVID
Updated : 5 years, 1 month ago IST
Washington [US], January 17 (ANI): Utilization of the diabetes drug metformin - before a determination of COVID-19 - is related with a triple reduction in mortality in COVID-19 patients with Type 2 diabetes, as per a racially assorted investigation at the University of Alabama at Birmingham.
Read More
Metformin use reduces risk of death for patients with COVID-19, diabetes
Updated : 5 years, 1 month ago IST
Washington [US], January 15 (ANI): Use of the diabetes drug metformin -- before a diagnosis of COVID-19 -- is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham.
Read More
Commonly used diabetic drug - Metformin, beneficial for non-diabetic patie
Updated : 6 years, 11 months ago IST
Washington DC [USA], Apr 17 (ANI): A new study claims that 'metformin', a commonly used diabetes drug, has the potential to reduce the risk of heart diseases in non-diabetic patients. Researchers also claim that metformin could reverse the harmful thickening of the heart muscle that leads
Read More
Gastric banding helps in slowing down prediabetes: Study
Updated : 7 years, 5 months ago IST
Washington D.C [USA], Oct 5 (ANI): A new study has found that gastric banding, a type of bariatric surgery for weight loss, is as effective as taking a pill of Metformin to slow down prediabetes.
Read More
Now, a process to thwart liver cancer cells
Updated : 8 years, 1 month ago IST
Washington D.C. [U.S.A.], Feb.7 (ANI): Scientists have found a new way to kill liver cancer cells and inhibit tumour growth. They have developed a two-way process to achieve the goal and starve the liver cancer.
Read More